Table 4.
Univariate and multivariate analysis of treatment response in all patients.
| Univariable OR | Multivariable OR | |||
|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | |
| Group | P = .123 | |||
| Demographic characteristics | ||||
| Age | P = .851 | |||
| Sex | ||||
| Female | 0.005 (0.165–0.731) | P = .005 | P = .099 | |
| Male | ||||
| PLT (109/L) | 0.993 (0.989–0.997) | P < .001 | 0.992 (0.987–0.998) | P = .009 |
| Immunological indicators | ||||
| IgA (g/L) | P = .194 | |||
| IgG (g/L) | 1.055 (1.012–1.100) | P = .013 | P = .387 | |
| IgM (g/L) | P = .987 | |||
| IgG:IgM | P = .978 | |||
| Biochemical indicators | ||||
| ALT (U/L) | P = .757 | |||
| AST (U/L) | P = .399 | |||
| GGT (U/L) | 1.003 (1.002–1.006) | P < .001 | P = .349 | |
| ALP (U/L) | 1.010 (1.007–1.013) | P < .001 | 1.010 (1.005–1.015) | P < .001 |
| ALB (g/L) | 0.841 (0.797–0.887) | P < .001 | 0.846 (0.774–0.924) | P < .001 |
| TBIL (μmol/L) | 1.039 (1.021–1.057) | P < .001 | P = .573 | |
The multivariate model was adjusted for sex, PLT, IgG, GGT, ALP, ALB, and TBIL.
ALB = albumin, ALP = alkaline phosphatase, ALT = alanine amino-transferase, AST = aspartate aminotransferase, CI = confidence interval, GGT = γ-glutamyl transpeptidase, IgA = immunoglobulin A, IgG = immunoglobulin G, IgM = immunoglobulin M, PLT = plateles, OR = odds ratio, TBIL = total bilirubin.